New study uses virtual tools to track achondroplasia over time
NCT ID NCT06168201
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study observes about 170 children and adults with achondroplasia in the United States over roughly 5 years. Researchers will collect health records and questionnaires to track growth, medical issues, surgeries, and quality of life. The goal is to better understand the condition and how treatments like VOXZOGO™ are used in real life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030-2316, United States
-
Johns Hopkins University (JHU)
RECRUITINGBaltimore, Maryland, 21205, United States
-
PicnicHealth
RECRUITINGSan Francisco, California, 94107, United States
-
Piedmont Health
RECRUITINGStatesville, North Carolina, 28625, United States
-
Sanford Health
RECRUITINGSioux Falls, South Dakota, 57115, United States
-
UCSF
RECRUITINGOakland, California, 94609, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45229, United States
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53726, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly shot help children with achondroplasia grow taller?
- Can growth hormone boost height in children with dwarfism?
- Weekly shot may boost growth in kids with dwarfism
- Experimental achondroplasia drug trial halted early
- No treatment, just tracking: PROPEL study watches how kids with achondroplasia grow
- New drug aims to boost height in kids with dwarfism